Few studies have assessed the use of osteopathic manipulative treatment (OMT) and subsequent patient-reported outcomes.
Extensive anecdotal reporting and some preliminary research indicate that OMT has a therapeutic benefit. 3, Examples of conditions positively influenced by OMT are low back pain, otitis media, postsurgical ileus, pneumonia, vertigo, chronic obstructive pulmonary disease, preterm labor, irritable bowel disease, ulcerative colitis, depression, fever, migraine headaches, chronic prostatitis, cough, tinnitus, and asthma. 14, 17, 19, 20, 25, 26, 28, 29, 31, [35] [36] [37] [38] [39] For people with low back pain, an expanding body of evidence indicates that OMT has a therapeutic benefit. [36] [37] [38] [39] A study 38 The randomized controlled trial (RCT) has been the gold standard in research to improve knowledge and advance medicine. In many cases, applying this design in human clinical studies is problematic. For instance, the cost to recruit and retain participants tends to be high.
Although designed to yield clear and important outcomes that are internally valid, generalizing outcomes is often limited. Further, interventions based on RCTs are often less efficacious than expected [40] [41] [42] [43] [44] [45] because the controlled T he aim of medicine is to provide safe, effective, efficient, timely, patient-centered, and equitable care. 1 An important aspect of advancing the practice of medicine is improving physician knowledge of the long-term course of common diseases and the impact of various treatments on those diseases. [2] [3] [4] [5] [6] Although the osteopathic medical profession has consistently promoted these aims, it has had limited success in systematically documenting its members' impact on such diseases. Osteopathic manipulative treatment (OMT) is a unique aspect of medical care provided by osteopathic physicians, but, to our knowledge, the most recent studies on the use of OMT within the adult population were conducted in the late 1990s. [7] [8] [9] [10] Johnson and Kurtz 7 surveyed physicians evaluating, in part, the conditions that they manage using OMT. In that study, more than half of the 950 physicians surveyed indicated that they used OMT in 5% or less of their patients. When OMT was used, it was used for musculoskeletal conditions in more than 50% of the patients. 7 A retrospective study 10 clinics; 2 were associated with the MSHMC and participated in the development of the tools needed to support DO-Touch.NET, and 2 were the first member sites of the network. All data were incorporated into an online data collection system that was tested and refined to ensure convenience in data collection and quality of data. The A.T. Still University-Kirksville and Penn State Hershey institutional review boards approved both the retrospective and prospective parts of the current study.
Retrospective Review
The International Classification of Diseases, 9th edition (ICD-9) 58 code for the primary diagnosis of patients receiving OMT was extracted from the billing records for 2007 at the 2 participating universities. At the MSHMC, the electronic billing system was queried to identify all office visits for which OMT was billed. At ATSU-KCOM, the electronic billing system generated a summary of each individual office visit, which required manual sorting and identification of the desired information. The summary report for ATSU-KCOM was reviewed 3 times to ensure accurate extraction of diagnosis data.
settings of RCTs are unrealistic in "real-world" practices and can create interventions that may be too complex or costly to integrate with existing activities. 40, 42, 43, 46 With In the present article, we report the preliminary findings of the DO-Touch.NET study, which was started before the formal formation of the PBRN. The objectives of the study, which is an ongoing prospective observational study on the current practice of OMT, are to determine the scope of conditions being managed with OMT and the characteristics of patients currently receiving OMT and to evaluate the patient-reported outcomes of treatment. We hypothesized that OMT would primarily be using standardized 0-to 10-point scales, with 0 indicating no problem and 10 indicating worst imaginable.
The frequency and duration of symptoms were also re- 
Results

Retrospective Review
For the 1-year retrospective review using billing data from 2 university-based sites, diagnosis data were col- patients who reported feeling better or much better 7 days after OMT having lower severity than the 3 subgroups with patients who reported feeling the same or worse 7 days after OMT. Symptom severity levels in the largest subgroup, with those who felt better or much better at both times, improved from pretreatment levels until post-OMT day 4, when severity leveled off. The mean (95% CI) decrease in symptom severity from before treatment to 7 days after OMT was 3.1 (2.5 to 3.6) points. Clinically meaningful improvement (ie, increase of ⩾30%) in symptom severity was seen in 85 of 107 patients (79%) in this subgroup with a large effect size (d=1.6). In the subgroup with patients who felt better or much better immediately but felt the same as before Overall, the 5 perceived response subgroups were significantly different on average symptom severity levels (P<.001) ( Figure 5) . Specifically, comparisons of the subgroups for each day showed the subgroups were not different on pretreatment severity levels but did differ on severity levels after 7 days, with the 2 subgroups with 
Comment
Results from both the retrospective and prospective com- Interference of symptoms with quality of life before OMT and at 7 days after OMT were compared (Table) .
There was significant improvement (ie, decrease in interference from chief complaints) of at least 1 point with usual/general activities, sleep, mood, and relationships Overall, the current study provides a more rigorously and comprehensively collected data set compared with those of previously published studies [7] [8] [9] 11, 22 because our data were prospectively collected from patients and physicians at the time of the office visit that included OMT.
This study design allows for corroboration between patient-and physician-reported data and between several pain and quality of life patient-reported measures. Previous studies considered general impressions of only patients or only physicians about osteopathic care. [7] [8] [9] 11, 22 There were several limitations in the current study.
First, in the retrospective review, the data that could be tant step in understanding the efficacy of OMT and its current practice characteristics.
In the current study, a large majority (92%) of patients reported a positive response to OMT immediately after treatment, whereas 72% reported that they still felt Consequently, somatohumeral changes may be responsible for the response noted in the current study. (continued)
